Picture of Wilmington logo

WIL Wilmington News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer CyclicalsAdventurousSmall CapHigh Flyer

REG - Wilmington PLC - Director/PDMR Shareholding

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220819:nRSS6742Wa&default-theme=true

RNS Number : 6742W  Wilmington PLC  19 August 2022

19 August 2022

 

Wilmington plc

Director/PDMR Shareholding

 

 

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation,
Wilmington plc (the 'Company') was advised on 19 August 2022 that:

 

·      Julian Davies, a PDMR, sold 1,773 ordinary shares of 5p each in
the Company on 19 August 2022 at an average of 282.2 pence per share. His
resultant holding of ordinary shares of 5p each is 5,428 which represent
 0.01% of the issued share capital with voting rights.

 

 

 

For further information, please contact:

 

Wilmington plc
 
020 7490 0049

 

Guy Millward, Company Secretary and Chief Financial Officer

 

 

 

Notes to Editors

Wilmington is the recognised knowledge leader and partner of choice for
information, education and networking in Risk & Compliance, Professional
and Healthcare areas. Wilmington employs close to 1,000 people and has
customers in 120 countries. Wilmington plc is a premium listed Company on the
main market of the London Stock Exchange.

 

 1.  Details of the Person Discharging Managerial Responsibility ("PDMR") / person
     closely associated with them ("PCA")

 a)  Name                                                         JULIAN DAVIES

 2.  Reason for the notification

 a)  Position /status                                             PDMR

 b)  Initial notification / amendment                             INITIAL NOTIFICATION

 3.  Details of the Issuer

 a)  Name                                                         WILMINGTON PLC

 b)  LEI code                                                     213800PFUQT4HHFYZJ63

 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted

 a)  Description of the financial instrument, type of instrument

     Identification code                                          ORDINARY SHARES IN WILMINGTON PLC

                                                                  ISIN: GB0009692319

 b)  Nature of the transaction                                    SALE OF ORDINARY SHARES
 c)  Price(s) and volume(s)                                       Price(s)  Volume(s)

                                                            2.822     1,773

 

 d)  Aggregated information

     Aggregated volume                                            N/A

     Price

 e)  Date of the transaction                                      19 AUGUST 2022

 f)  Place of the transaction                                     LONDON

 

 

d)

Aggregated information

Aggregated volume

Price

 

 

 

N/A

 

 

e)

Date of the transaction

19 AUGUST 2022

 

 

f)

Place of the transaction

LONDON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHPLMFTMTMBBFT

Recent news on Wilmington

See all news